Malignant neoplasm of left broad ligament
ICD-10 C57.12 is a billable code used to indicate a diagnosis of malignant neoplasm of left broad ligament.
C57.12 refers to a malignant neoplasm located in the left broad ligament, which is a peritoneal fold that extends from the sides of the uterus to the pelvic walls. This type of cancer is classified under gynecologic malignancies and can arise from various cell types, including epithelial, stromal, or germ cell origins. The broad ligament supports the uterus and contains blood vessels, nerves, and lymphatics, making it a critical area for gynecological health. Symptoms may include pelvic pain, abnormal bleeding, or a palpable mass. Diagnosis typically involves imaging studies such as ultrasound or MRI, followed by biopsy for histological confirmation. Staging of the tumor is crucial for determining the extent of disease and guiding treatment, which may include surgery, chemotherapy, or radiation therapy. The CA-125 blood test may be utilized as a tumor marker, particularly in monitoring treatment response or recurrence. Accurate coding for C57.12 requires thorough documentation of the tumor's characteristics, staging, and treatment plan.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of ovarian and uterine cancers, staging of pelvic tumors.
Ensure comprehensive documentation of tumor characteristics and treatment response.
Clear imaging reports indicating tumor location and characteristics.
Imaging for staging and follow-up of gynecologic malignancies.
Accurate descriptions of imaging findings are crucial for coding.
Performed for malignant neoplasm of the left broad ligament.
Operative report detailing the procedure and findings.
Gynecologic oncology specialists should ensure accurate coding of the procedure.
CA-125 is a tumor marker that can be elevated in cases of ovarian and related malignancies, including those affecting the broad ligament. It is often used to monitor treatment response and detect recurrence.
